Compare $DRMA vs $PMCB | Chartloom

Compare

$DRMA vs $PMCB

Dermata Therapeutics Inc · PharmaCyte Biotech Inc

DRMA

Dermata Therapeutics Inc

PMCB

PharmaCyte Biotech Inc

Compare $DRMA vs $PMCB

Comparing Dermata Therapeutics Inc and PharmaCyte Biotech Inc

DRMADermata Therapeutics Inc

PMCBPharmaCyte Biotech Inc

DRMADermata Therapeutics Inc

Market cap

$4M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

11.49x

Rev growth (TTM)

—

YTD performance

-53.2%

52W performance

-78.7%

FCF yield

-198.6%

PMCBPharmaCyte Biotech Inc

Market cap

$4M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-45.2%

52W performance

-60.4%

FCF yield

-90.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DRMA

PMCB

Detailed metrics comparison

DRMA

Dermata Therapeutics Inc

PMCB

PharmaCyte Biotech Inc

Market Cap

DRMA$4M

PMCB$4M

Enterprise Value

DRMA$-312K

PMCB$-13M

Price

DRMA$1.02

PMCB$0.40

P/E Ratio

DRMAN/A

PMCBN/A

P/S Ratio

DRMA0.00x

PMCB107.65x

EV/Sales

DRMA0.00x

PMCB-336.93x

EV/EBITDA

DRMA0.00x

PMCB0.00x

P/B Ratio

DRMA1.27x

PMCB0.14x

P/FCF Ratio

DRMAN/A

PMCBN/A

EV/FCF

DRMA0.04x

PMCB3.40x

PEG Ratio

DRMAN/A

PMCBN/A

Forward P/E (NTM)

DRMAN/A

PMCBN/A

Forward P/S (NTM)

DRMA11.49x

PMCBN/A

Revenue (TTM)

DRMA$0

PMCB$0

Revenue Growth (YoY)

DRMAN/A

PMCBN/A

Forward Rev Growth

DRMA650.0%

PMCB0.0%

Gross Margin (TTM)

DRMA0.0%

PMCB81.7%

Operating Margin (TTM)

DRMA0.0%

PMCB0.0%

EBITDA Margin (TTM)

DRMA0.0%

PMCB0.0%

Net Margin (TTM)

DRMA0.0%

PMCB0.0%

FCF Margin (TTM)

DRMAN/A

PMCBN/A

Net Income (TTM)

DRMA$-8M

PMCB$-21M

FCF (TTM)

DRMA$-8M

PMCB$-4M

EPS (TTM)

DRMA-$2.08

PMCB-$1.92

ROE (TTM)

DRMA-16667.0%

PMCB-4588.0%

ROA (TTM)

DRMA-13014.0%

PMCB-3307.0%

ROIC (TTM)

DRMA-16667.0%

PMCB-4588.0%

Cash

DRMA$4M

PMCB$18M

Debt

DRMA$0

PMCB$0

Net Cash/Debt

DRMA$4M

PMCB$18M

Current Ratio (TTM)

DRMA2.81x

PMCB40.30x

Quick Ratio (TTM)

DRMA2.62x

PMCB40.25x

Debt/Equity (TTM)

DRMA0.00x

PMCB0.00x

Debt/Assets (TTM)

DRMA0.0%

PMCB0.0%

Interest Coverage (TTM)

DRMAN/A

PMCBN/A

Net Debt/EBITDA (TTM)

DRMA0.00x

PMCB0.00x

Beta

DRMA0.58

PMCB0.74

52W Performance

DRMA-78.7%

PMCB-60.4%

YTD Performance

DRMA-53.2%

PMCB-45.2%

% from 52W High

DRMA-78.9%

PMCB-73.2%

% from 52W Low

DRMA7.3%

PMCB21.1%

Asset Turnover (TTM)

DRMA0.00x

PMCB0.02x

FCF Yield (TTM)

DRMA-198.6%

PMCB-90.7%

Earnings Yield (TTM)

DRMA-204.1%

PMCB-475.0%

Dividend Yield (TTM)

DRMAN/A

PMCBN/A

Rule of 40

DRMA0.0

PMCB0.0

EV/GP/RG

DRMAN/A

PMCBN/A

Ticker research

View DRMA research View PMCB research

Metric	DRMA Dermata Therapeutics Inc	PMCB PharmaCyte Biotech Inc
Market & Valuation
Market Cap	$4M	$4M
Enterprise Value	$-312K	$-13M
Price	$1.02	$0.40
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	107.65x
EV/Sales	0.00x	-336.93x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.27x	0.14x
P/FCF Ratio	N/A	N/A
EV/FCF	0.04x	3.40x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	11.49x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	650.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	81.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-8M	$-21M
FCF (TTM)	$-8M	$-4M
EPS (TTM)	-$2.08	-$1.92
ROE (TTM)	-16667.0%	-4588.0%
ROA (TTM)	-13014.0%	-3307.0%
ROIC (TTM)	-16667.0%	-4588.0%
Financial Health
Cash	$4M	$18M
Debt	$0	$0
Net Cash/Debt	$4M	$18M
Current Ratio (TTM)	2.81x	40.30x
Quick Ratio (TTM)	2.62x	40.25x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	0.74
52W Performance	-78.7%	-60.4%
YTD Performance	-53.2%	-45.2%
% from 52W High	-78.9%	-73.2%
% from 52W Low	7.3%	21.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-198.6%	-90.7%
Earnings Yield (TTM)	-204.1%	-475.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DRMA research	View PMCB research

Valuation

P/S Ratio

DRMA

0.00x

PMCB

107.65x

EV/FCF

DRMA

0.04x

PMCB

3.40x

Growth & revenue

Forward Revenue Growth

DRMA

650.0%

PMCB

0.0%

Profitability & performance

Gross Margin

PMCB

81.7%

DRMA

0.0%

ROE

PMCB

-4588.0%

DRMA

-16667.0%

FCF Yield %

PMCB

-90.7%

DRMA

-198.6%

52-Week Performance

PMCB

-60.4%

DRMA

-78.7%

Detailed metrics comparison

DRMA

Dermata Therapeutics Inc

PMCB

PharmaCyte Biotech Inc

Market Cap

DRMA$4M

PMCB$4M

Enterprise Value

DRMA$-312K

PMCB$-13M

Price

DRMA$1.02

PMCB$0.40

P/E Ratio

DRMAN/A

PMCBN/A

P/S Ratio

DRMA0.00x

PMCB107.65x

EV/Sales

DRMA0.00x

PMCB-336.93x

EV/EBITDA

DRMA0.00x

PMCB0.00x

P/B Ratio

DRMA1.27x

PMCB0.14x

P/FCF Ratio

DRMAN/A

PMCBN/A

EV/FCF

DRMA0.04x

PMCB3.40x

PEG Ratio

DRMAN/A

PMCBN/A

Forward P/E (NTM)

DRMAN/A

PMCBN/A

Forward P/S (NTM)

DRMA11.49x

PMCBN/A

Revenue (TTM)

DRMA$0

PMCB$0

Revenue Growth (YoY)

DRMAN/A

PMCBN/A

Forward Rev Growth

DRMA650.0%

PMCB0.0%

Gross Margin (TTM)

DRMA0.0%

PMCB81.7%

Operating Margin (TTM)

DRMA0.0%

PMCB0.0%

EBITDA Margin (TTM)

DRMA0.0%

PMCB0.0%

Net Margin (TTM)

DRMA0.0%

PMCB0.0%

FCF Margin (TTM)

DRMAN/A

PMCBN/A

Net Income (TTM)

DRMA$-8M

PMCB$-21M

FCF (TTM)

DRMA$-8M

PMCB$-4M

EPS (TTM)

DRMA-$2.08

PMCB-$1.92

ROE (TTM)

DRMA-16667.0%

PMCB-4588.0%

ROA (TTM)

DRMA-13014.0%

PMCB-3307.0%

ROIC (TTM)

DRMA-16667.0%

PMCB-4588.0%

Cash

DRMA$4M

PMCB$18M

Debt

DRMA$0

PMCB$0

Net Cash/Debt

DRMA$4M

PMCB$18M

Current Ratio (TTM)

DRMA2.81x

PMCB40.30x

Quick Ratio (TTM)

DRMA2.62x

PMCB40.25x

Debt/Equity (TTM)

DRMA0.00x

PMCB0.00x

Debt/Assets (TTM)

DRMA0.0%

PMCB0.0%

Interest Coverage (TTM)

DRMAN/A

PMCBN/A

Net Debt/EBITDA (TTM)

DRMA0.00x

PMCB0.00x

Beta

DRMA0.58

PMCB0.74

52W Performance

DRMA-78.7%

PMCB-60.4%

YTD Performance

DRMA-53.2%

PMCB-45.2%

% from 52W High

DRMA-78.9%

PMCB-73.2%

% from 52W Low

DRMA7.3%

PMCB21.1%

Asset Turnover (TTM)

DRMA0.00x

PMCB0.02x

FCF Yield (TTM)

DRMA-198.6%

PMCB-90.7%

Earnings Yield (TTM)

DRMA-204.1%

PMCB-475.0%

Dividend Yield (TTM)

DRMAN/A

PMCBN/A

Rule of 40

DRMA0.0

PMCB0.0

EV/GP/RG

DRMAN/A

PMCBN/A

Ticker research

View DRMA research View PMCB research

Metric	DRMA Dermata Therapeutics Inc	PMCB PharmaCyte Biotech Inc
Market & Valuation
Market Cap	$4M	$4M
Enterprise Value	$-312K	$-13M
Price	$1.02	$0.40
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	107.65x
EV/Sales	0.00x	-336.93x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.27x	0.14x
P/FCF Ratio	N/A	N/A
EV/FCF	0.04x	3.40x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	11.49x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	650.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	81.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-8M	$-21M
FCF (TTM)	$-8M	$-4M
EPS (TTM)	-$2.08	-$1.92
ROE (TTM)	-16667.0%	-4588.0%
ROA (TTM)	-13014.0%	-3307.0%
ROIC (TTM)	-16667.0%	-4588.0%
Financial Health
Cash	$4M	$18M
Debt	$0	$0
Net Cash/Debt	$4M	$18M
Current Ratio (TTM)	2.81x	40.30x
Quick Ratio (TTM)	2.62x	40.25x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	0.74
52W Performance	-78.7%	-60.4%
YTD Performance	-53.2%	-45.2%
% from 52W High	-78.9%	-73.2%
% from 52W Low	7.3%	21.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-198.6%	-90.7%
Earnings Yield (TTM)	-204.1%	-475.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DRMA research	View PMCB research